Corbus Pharmaceuticals Holdings (CRBP) Interest & Investment Income (2013 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Interest & Investment Income of $23311.0 for Q2 2021, up 84.29% year-over-year from $12649.0 in Q2 2020, and up 181.04% quarter-over-quarter from -$28765.0 in Q1 2021.
Corbus Pharmaceuticals Holdings (CRBP) Interest & Investment Income (2013 - 2021) Analysis & Trends
Corbus Pharmaceuticals Holdings' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $23311.0 for Q2 2021.
- In Q2 2021, Interest & Investment Income rose 84.29% year-over-year to $23311.0; the TTM figure through Jun 2021 stood at $109188.0 (down 87.84% YoY), while the FY2019 annual figure was $1.2 million, up 24.92% from the prior year.
- Interest & Investment Income for Q2 2021 stood at $23311.0, up from -$28765.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $448717.0 in Q2 2019, with the low at -$28765.0 in Q1 2021.
- The 3-year median for Interest & Investment Income is $62652.0 (2020), against an average of $148750.0.
- Peak annual rise in Interest & Investment Income reached 84.29% in 2021, while the deepest fall reached 128.2% in 2021.
- Corbus Pharmaceuticals Holdings' Interest & Investment Income stood at $448717.0 in 2019, then slumped by 97.18% to $12649.0 in 2020, then surged by 84.29% to $23311.0 in 2021.
- Business Quant data shows CRBP's Interest & Investment Income at $23311.0 in Q2 2021, -$28765.0 in Q1 2021, and $12649.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 23,311.00 |
| Mar 31, 2021 | -28,765.00 |
| Jun 30, 2020 | 12,649.00 |
| Mar 31, 2020 | 101,993.00 |
| Jun 30, 2019 | 448,717.00 |
| Mar 31, 2019 | 334,595.00 |
| Mar 31, 2016 | 1,070.00 |
| Dec 31, 2015 | 1,272.00 |
| Sep 30, 2015 | 1,037.00 |
| Jun 30, 2015 | 548.00 |
| Mar 31, 2015 | 560.00 |
| Dec 31, 2014 | 690.00 |
| Sep 30, 2014 | 802.00 |
| Jun 30, 2014 | 578.00 |
| Mar 31, 2014 | 45.00 |
| Dec 31, 2013 | 59.00 |
| Sep 30, 2013 | 128.00 |